Experienced pharmaceutical and biotech commercial strategy executive, with deep expertise in the areas of market access, brand strategy, pricing & reimbursement, product launch, market research, and healthcare policy in the US and globally. Therapeutic experience across numerous primary and specialty medicine categories including oncology, immuno-oncology, immunology, vaccines, neuroscience, Alzheimer's, diabetes, hemophilia, respiratory, cardiovascular, infectious disease, rare and orphan diseases, and gene therapy.Specialties: Payer Strategy, Marketing Strategy, Value Strategy, Pricing and Reimbursement Strategy, Value-based Pricing, Product Launch, New Product Development, Lifecycle Management, Health Economics, Contracting Strategy, Global Market Access, US Managed Markets, Commercial Payers (MCOs and PBMs), Medicare (Part B and Part D), Medicaid, Integrated Delivery Networks (IDNs), Accountable Care Organizations (ACOs), Specialty Pharmacy Providers, Oncology Pathways, Value Frameworks, Provider and Patient Access Services, Physician/Prescriber Strategy, Sales Force Effectiveness, Account Management, Market Research, Business Analytics, Targeting, Segmentation, ROI Analysis, Global and Emerging Markets, Pharmaceuticals, Specialty Pharma, Biosimilars, Biotech.
Listed skills include Pharmaceutical Industry, Product Launch, Sales Effectiveness, Biotechnology, and 46 others.